Close
Help





JOURNAL

Clinical Medicine Reviews in Vascular Health

Pharmacotherapeutic Options for the Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes

Submit a Paper


Clinical Medicine Reviews in Vascular Health 2012:4 43-53

Review

Published on 14 May 2012

DOI: 10.4137/CMRVH.S7434


Further metadata provided in PDF

Download Article PDF


Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Vascular Health

Abstract

Type 2 diabetes is well recognized as an independent risk factor for cardiovascular disease (CVD). In turn, CVD is the leading cause of morbidity and mortality in patients with type 2 diabetes. The impact of glycemic control in reducing microvascular complications is now well accepted. Although improving glycemic control is also beneficial for the prevention of macrovascular diseases, adequate treatment of hypertension and hyperlipidemia is also essential. In fact, studies have repeatedly demonstrated the safety and efficacy of antihypertensive and antihyperlipidemic therapies for the prevention of CVD in patients with type 2 diabetes. This article reviews the impact of commonly used antidiabetic, antihyperlipidemic, antihypertensive and antiplatelet agents on reducing CVD risk in patients with type 2 diabetes.



Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)





Quick Links


New article and journal news notification services